These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35785706)

  • 1. New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy.
    Wang X; Xu Y; Sun Q; Zhou X; Ma W; Wu J; Zhuang J; Sun C
    Biomed Pharmacother; 2022 Sep; 153():113343. PubMed ID: 35785706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions.
    Yang S; Wang M; Hua Y; Li J; Zheng H; Cui M; Huang N; Liu Q; Liao Q
    Cancer Lett; 2024 Mar; 584():216610. PubMed ID: 38244910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
    Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
    Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.
    Guo S; Chen X; Guo C; Wang W
    Expert Rev Mol Med; 2022 Apr; 24():e17. PubMed ID: 35400355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing.
    Wang J; Zhu N; Su X; Gao Y; Yang R
    Front Immunol; 2023; 14():1264774. PubMed ID: 38347955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
    Liu C; Zhang Y; Li X; Wang D
    Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
    Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
    Front Immunol; 2020; 11():1731. PubMed ID: 32849616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature.
    Shi L; Mao H; Ma J
    BMC Med Genomics; 2024 May; 17(1):145. PubMed ID: 38802881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
    Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
    J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
    Xu L; Xie X; Luo Y
    Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma.
    Zhang L; Jiang Y; Zhang G; Wei S
    Front Immunol; 2023; 14():1238233. PubMed ID: 37731483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
    Zins K; Abraham D
    Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
    Ding S; Chen X; Shen K
    Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
    Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular trajectories of tumor-associated macrophages decipher the heterogeneity of pancreatic cancer.
    Lin J; Lu F; Wu Y; Huang H; Pan Y
    Funct Integr Genomics; 2023 Nov; 23(4):343. PubMed ID: 37991591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer.
    Li C; Xu X; Wei S; Jiang P; Xue L; Wang J;
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33504575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.